Barclays’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.8M | Sell |
492,900
-2,832,200
| -85% | -$75.4M | ﹤0.01% | 1275 |
|
|
2025
Q4 | $82.8M | Buy |
3,325,100
+1,982,200
| +148% | +$50M | 0.02% | 572 |
|
|
2025
Q3 | $34.2M | Buy |
+1,342,900
| New | +$33.1M | 0.01% | 947 |
|
|
2025
Q2 | – | Sell |
-203,800
| Closed | -$5.16M | – | 5464 |
|
|
2025
Q1 | $5.16M | Sell |
203,800
-85,700
| -30% | -$2.24M | ﹤0.01% | 1885 |
|
|
2024
Q4 | $7.68M | Hold |
289,500
| – | – | ﹤0.01% | 1785 |
|
|
2024
Q3 | $8.38M | Sell |
289,500
-4,646,900
| -94% | -$136M | ﹤0.01% | 1605 |
|
|
2024
Q2 | $138M | Buy |
+4,936,400
| New | +$136M | 0.04% | 306 |
|
|
2024
Q1 | – | Sell |
-790,000
| Closed | -$22.7M | – | 5304 |
|
|
2023
Q4 | $22.7M | Buy |
790,000
+510,000
| +182% | +$15.4M | 0.01% | 997 |
|
|
2023
Q3 | $9.29M | Sell |
280,000
-331,400
| -54% | -$11.7M | 0.01% | 1030 |
|
|
2023
Q2 | $22.4M | Buy |
611,400
+52,000
| +9% | +$2.02M | 0.01% | 682 |
|
|
2023
Q1 | $22.8M | Buy |
559,400
+13,900
| +3% | +$600K | 0.01% | 789 |
|
|
2022
Q4 | $28M | Buy |
+545,500
| New | +$26.2M | 0.01% | 729 |
|
|
2022
Q3 | – | Sell |
-180,000
| Closed | -$9.44M | – | 5053 |
|
|
2022
Q2 | $9.44M | Buy |
+180,000
| New | +$9.17M | 0.01% | 1035 |
|
|
2022
Q1 | – | Sell |
-64,600
| Closed | -$3.81M | – | 5459 |
|
|
2021
Q4 | $3.81M | Sell |
64,600
-239,600
| -79% | -$11.9M | ﹤0.01% | 1903 |
|
|
2021
Q3 | $13.1M | Sell |
304,200
-345,200
| -53% | -$15.3M | 0.01% | 1055 |
|
|
2021
Q2 | $25.4M | Buy |
649,400
+28,000
| +5% | +$1.09M | 0.01% | 780 |
|
|
2021
Q1 | $22.5M | Sell |
621,400
-12,000
| -2% | -$426K | 0.01% | 755 |
|
|
2020
Q4 | $23.3M | Sell |
633,400
-46,641
| -7% | -$1.71M | 0.01% | 777 |
|
|
2020
Q3 | $23.7M | Buy |
680,041
+349,401
| +106% | +$12.2M | 0.01% | 673 |
|
|
2020
Q2 | $10.3M | Sell |
330,640
-523,311
| -61% | -$17.8M | 0.01% | 943 |
|
|
2020
Q1 | $26.4M | Sell |
853,951
-27,720
| -3% | -$945K | 0.02% | 530 |
|
|
2019
Q4 | $32.8M | Sell |
881,671
-28,458
| -3% | -$1.01M | 0.02% | 692 |
|
|
2019
Q3 | $31M | Sell |
910,129
-153,041
| -14% | -$5.57M | 0.02% | 653 |
|
|
2019
Q2 | $43.7M | Buy |
1,063,170
+266,030
| +33% | +$10.6M | 0.03% | 534 |
|
|
2019
Q1 | $32.1M | Buy |
797,140
+45,322
| +6% | +$1.82M | 0.02% | 611 |
|
|
2018
Q4 | $31.1M | Buy |
751,818
+136,177
| +22% | +$5.65M | 0.02% | 551 |
|
|
2018
Q3 | $25.7M | Sell |
615,641
-65,981
| -10% | -$2.54M | 0.02% | 724 |
|
|
2018
Q2 | $23.5M | Sell |
681,622
-311,773
| -31% | -$10.7M | 0.02% | 703 |
|
|
2018
Q1 | $33.4M | Buy |
993,395
+491,059
| +98% | +$16.9M | 0.03% | 597 |
|
|
2017
Q4 | $17.3M | Buy |
502,336
+189,930
| +61% | +$6.48M | 0.01% | 884 |
|
|
2017
Q3 | $10.6M | Sell |
312,406
-1,443,769
| -82% | -$46.4M | 0.01% | 1022 |
|
|
2017
Q2 | $56M | Buy |
1,756,175
+544,075
| +45% | +$17.2M | 0.06% | 249 |
|
|
2017
Q1 | $39.3M | Sell |
1,212,100
-194,885
| -14% | -$6.14M | 0.04% | 318 |
|
|
2016
Q4 | $43.4M | Buy |
1,406,985
+343,499
| +32% | +$10.5M | 0.05% | 309 |
|
|
2016
Q3 | $34.2M | Buy |
1,063,486
+23,504
| +2% | +$786K | 0.04% | 360 |
|
|
2016
Q2 | $34.7M | Sell |
1,039,982
-631,346
| -38% | -$20.1M | 0.05% | 338 |
|
|
2016
Q1 | $46M | Sell |
1,671,328
-2,184,942
| -57% | -$62.4M | 0.07% | 242 |
|
|
2015
Q4 | $117M | Buy |
3,856,270
+660,120
| +21% | +$20.8M | 0.14% | 121 |
|
|
2015
Q3 | $94M | Sell |
3,196,150
-1,973,931
| -38% | -$63.3M | 0.11% | 150 |
|
|
2015
Q2 | $162M | Sell |
5,170,081
-3,777,641
| -42% | -$123M | 0.18% | 80 |
|
|
2015
Q1 | $289M | Buy |
8,947,722
+3,977,796
| +80% | +$126M | 0.33% | 33 |
|
|
2014
Q4 | $146M | Buy |
4,969,926
+1,779,995
| +56% | +$51M | 0.14% | 108 |
|
|
2014
Q3 | $87.8M | Sell |
3,189,931
-718,090
| -18% | -$20.2M | 0.08% | 183 |
|
|
2014
Q2 | $108M | Buy |
3,908,021
+909,707
| +30% | +$25.9M | 0.11% | 130 |
|
|
2014
Q1 | $91M | Sell |
2,998,314
-291,642
| -9% | -$8.7M | 0.1% | 171 |
|
|
2013
Q4 | $93.6M | Sell |
3,289,956
-618,908
| -16% | -$18M | 0.1% | 170 |
|
|
2013
Q3 | $104M | Sell |
3,908,864
-1,947,792
| -33% | -$53M | 0.12% | 114 |
|
|
2013
Q2 | $156M | Buy |
+5,856,656
| New | +$162M | 0.19% | 64 |
|
Other funds holding PFE
VCM
VPM
Barclays's PFE Position: Q1 2026 in Review
Barclays reduced its Pfizer (PFE) stake by 19% in Q1 2026, selling an estimated $91.7M and leaving 14,689,187 shares worth $412M. The position accounts for 0.1% of the portfolio, ranked #150.
Barclays first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $892M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Barclays held 14,689,187 shares of Pfizer worth $412M as of Q1 2026.
- Barclays sold 3,444,802 Pfizer shares in Q1 2026, an estimated $91.7M.
- Pfizer made up 0.1% of Barclays's portfolio in Q1 2026, its #150 holding.
- Barclays first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Barclays's Pfizer position peaked at $892M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.